Green: These inhalers tend to be for long-acting beta-agonist preventer medication, most often used to help reduce symptoms of respiratory conditions like asthma or COPD. These must also be taken ...

In patients with chronic obstructive pulmonary disease (COPD), the first year of using single-inhaler triple therapy is associated with slightly more major adverse cardiovascular events (MACE) than ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...

That said, in one study of people with moderate to severe COPD, there was no difference in measured outcomes (like COPD symptoms, use of relief medications, or change in FEV1 after using an inhaler).

Experts lay bare the health effects of breathing in wildfire smoke and the steps that can be taken to reduce one's risk.

“We are proud to continue advancing our asthma and COPD inhaled drug program, achieving key clinical development milestones on schedule,” said Xian-Ming Zeng, Ph.D., CEO of Transpire Bio.

Bronchodilators Don't Improve Smoking-Related Respiratory Symptoms in People Without COPD Sep. 5, 2022 — Researchers have found that dual bronchodilators -- long-lasting inhalers that relax the ...

13, 2025 (GLOBE NEWSWIRE) -- Transpire Bio Inc., an integrated clinical-stage biopharmaceutical company dedicated to developing inhaled medicines, today announced the commencement of a new human ...

Purpose: Product- and patient-specific factors that may influence the selection of an inhaled anesthetic agent are discussed in four case studies. Summary: The cardiovascular, respiratory ...

The nation’s second largest city and its surrounding areas are now experiencing hazardous air quality - here's how these ...